• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

Balstilimab Antibody – Monoclonal

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS156645

PD-1 monoclonal antibody balstilimab is used to treat cervical cancer, balstilimab monotherapy and anti-CTLA-4 monoclonal antibody zalifrelimab combined with balstilimab for metastatic cervical cancer. More details

DISCONTINUED
Click here to view our similar product(s) OR click here to contact our technical support team for suitable replacement.
Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Product Name
Balstilimab, Monoclonal Antibody
Full Product Name
Balstilimab
Product Synonym Names
AGEN2034; PDCD1; PD1; CD279
Clonality
Monoclonal
Isotype
IgG4-kappa
Species Reactivity
Human
Form/Format
Liquid. Supplied as solution form in PBS pH 7.4.
Concentration
1mg/ml (lot specific)
Preparation and Storage
Store at -80 degree C
CAS Number
2230167-06-1
Host Species
Human

Product Categories/Family for anti-Balstilimab antibody

Antibody drug analogues
ISO Certification
Manufactured in an ISO 9001:2015 Certified Laboratory.

Other Notes

Small volumes of anti-Balstilimab antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for Balstilimab purchase

MBS156645 is an antibody targeting Balstilimab. Reactive in Human.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000